Sumitomo Pharma America, INC. (Formerly Sunovion Pharmaceuticals INC.)

Based in MA

🤖

AI Overview

With $7.5M in lobbying spend across 25 quarterly filings, Sumitomo Pharma America, INC. (Formerly Sunovion Pharmaceuticals INC.) is one of the biggest lobbying spenders in Washington. Their lobbying covers 1 issue area. Active from 2018 to 2024.

$7.5M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$1.3M
2019	$1.3M
2020	$1.1M
2021	$1.1M
2022	$1.3M
2023	$1.1M
2024	$210K

Issues Lobbied

Health Issues

Lobbying Firms

Sumitomo Pharma America, Inc.(formerly Sunovion Pharmaceuticals INC.)

Lobbyists

Eric Rasmussen Bela Sastry Theresa Jolivette

Government Agencies Targeted

These are the government entities that Sumitomo Pharma America, INC. (Formerly Sunovion Pharmaceuticals INC.) disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATEOffice of Management & Budget (OMB)Centers For Medicare and Medicaid Services (CMS)

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

Discussions regarding protected classes reform

Part D proposed rule and LIS co-pays

Part B Payment reform

Massachusetts 1115 Medicaid waiver amendment

FDA Regulatory Review

Opioid Substance Abuse legi

Discussions regarding protected classes reform

Part B drug coverage and Payment reform

Massachusetts 1115 Medicaid waiver amendment

FDA Regulatory Review

Opioid Substance Abuse legislation

Medicare Pa